UCB Unveils Groundbreaking TK2d Research at Upcoming UMDF Conference in 2025 UCB prepares to showcase innovative research on thymidine kinase 2 deficiency (TK2d) at the 2025 UMDF Conference, emphasizing patient experiences.

UCB Unveils Groundbreaking TK2d Research at Upcoming UMDF Conference in 2025 #United_States #St._Louis #UCB #Thymidine_Kinase #UMDF

New Investigational Therapy for Thymidine Kinase 2 Deficiency Shows Promise at MDA 2025 Conference UCB has presented compelling data at the MDA 2025 Conference, showing the potential life-saving benefits of their new treatment for thymidine kinase 2 deficiency.

New Investigational Therapy for Thymidine Kinase 2 Deficiency Shows Promise at MDA 2025 Conference #UCB #Brussels #Belgium #Thymidine_Kinase #TK2d